| D-2026-2068-DEV0HD-0001-0001 |
No |
$0 |
$0 |
|
|
Rec. 1: The DoD OIG recommended that the Under Secretary of Defense for Personnel and Readiness, in coordination with the Under Secretary of Defense for Acquisition and Sustainment and Secretaries of the Military Departments, develop and implement policy that fully complies with the requirements of section 706 of the FY 2024 National Defense Authorization Act.
|
| D-2026-2068-DEV0HD-0001-0002.a |
No |
$0 |
$0 |
|
|
Rec. 2.a: The DoD OIG recommended that the Secretary of the Army, in coordination with the Director of the Defense Health Agency, develop and implement a plan with milestones to make naloxone available to Military Department Security Forces in accordance with the requirements of section 706 of the FY 2024 National Defense Authorization Act and Executive Action 15.
|
| D-2026-2068-DEV0HD-0001-0002.b |
No |
$0 |
$0 |
|
|
Rec. 2.b: The DoD OIG recommended that the Secretary of the Navy, in coordination with the Director of the Defense Health Agency, develop and implement a plan with milestones to make naloxone available to Military Department Security Forces in accordance with the requirements of section 706 of the FY 2024 National Defense Authorization Act and Executive Action 15.
|
| D-2026-2068-DEV0HD-0001-0002.c |
No |
$0 |
$0 |
|
|
Rec. 2.c: The DoD OIG recommended that the Secretary of the Air Force, in coordination with the Director of the Defense Health Agency, develop and implement a plan with milestones to make naloxone available to Military Department Security Forces in accordance with the requirements of section 706 of the FY 2024 National Defense Authorization Act and Executive Action 15.
|
| D-2026-2068-DEV0HD-0001-0003 |
No |
$0 |
$0 |
|
|
Rec. 3: The DoD OIG recommended that the Director of the Defense Health Agency annually provide the Director of Morale, Welfare, Recreation, and Resale Policy with data of beneficiaries prescription opioid use from military treatment facilities.
|
| D-2026-2068-DEV0HD-0001-0004 |
No |
$0 |
$0 |
|
|
Rec. 4: The DoD OIG recommended that the Director of Morale, Welfare, Recreation, and Resale Policy, who reports to the Under Secretary of Defense for Personnel and Readiness, apply the beneficiaries prescription opioid use data provided annually by the Director of the Defense Health Agency to develop and implement a plan with milestones to make naloxone products available for online and in-store purchases, as appropriate.
|
| D-2026-2068-DEV0HD-0001-0005.a |
No |
$0 |
$0 |
|
|
Rec. 5.a: The DoD OIG recommended that the Secretary of the Army, in coordination with the Under Secretary of Defense for Personnel and Readiness, develop and implement a plan for tracking, identifying trends of, and analyzing data related to the illegal use of fentanyl in accordance with the requirements of section 706 of the FY 2024 National Defense Authorization Act.
|
| D-2026-2068-DEV0HD-0001-0005.b |
No |
$0 |
$0 |
|
|
Rec. 5.b: The DoD OIG recommended that the Secretary of the Navy, in coordination with the Under Secretary of Defense for Personnel and Readiness, develop and implement a plan for tracking, identifying trends of, and analyzing data related to the illegal use of fentanyl in accordance with the requirements of section 706 of the FY 2024 National Defense Authorization Act.
|
| D-2026-2068-DEV0HD-0001-0005.c |
No |
$0 |
$0 |
|
|
Rec. 5.c: The DoD OIG recommended that the Secretary of the Air Force, in coordination with the Under Secretary of Defense for Personnel and Readiness, develop and implement a plan for tracking, identifying trends of, and analyzing data related to the illegal use of fentanyl in accordance with the requirements of section 706 of the FY 2024 National Defense Authorization Act.
|
